Pathway-targeted pharmacogenomics of CYP1A2 in human liver

Pathway-targeted pharmacogenomics of CYP1A2 in human liver

The human drug metabolizing cytochrome P450 (CYP) 1A2, is one of the major P450 isoforms contributing by about 5-20% to the hepatic P450 pool and catalyzing oxidative biotransformation of up to 10% of clinically relevant drugs including clozapine and caffeine. CYP1A2 activity is interindividually hi...

Full description

Bibliographic Details
Main Authors:	Kathrin eKlein, Stefan eWinter, Miia eTurpeinen, Matthias eSchwab, Ulrich M Zanger
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2010-11-01
Series:	Frontiers in Pharmacology
Subjects:	Pharmacogenetics pharmacogenomics SNP cytochrome P450 multivariate analysis candidate gene
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2010.00129/full

Similar Items

Paraoxonase (PON1 and PON3) polymorphisms: impact on liver expression and atorvastatin-lactone hydrolysis
by: Stephan eRiedmaier, et al.
Published: (2011-07-01)

Pharmacogenomics of cytochrome P450 3A4 (CYP3A4): recent progress towards the missing heritability problem
by: Kathrin eKlein, et al.
Published: (2013-02-01)

Peroxisome proliferator-activated receptor alpha, PPARα, directly regulates transcription of cytochrome P450 CYP2C8
by: Maria eThomas, et al.
Published: (2015-11-01)

Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen
by: Theodore J. Wigle, et al.
Published: (2017-12-01)

Pharmacogenomics of CYP2C9: Functional and Clinical Considerations
by: Ann K. Daly, et al.
Published: (2017-12-01)

Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective
by: Gurusamy Umamaheswaran, et al.
Published: (2014-01-01)

INTEGRATING PHARMACOGENOMICS INTO CLINICAL PRACTICE
by: Gurinder Johal, et al.
Published: (2016-05-01)

Pharmacogenetics of schizophrenia in real clinical practice: a clinical case
by: R. F. Nasyrova, et al.
Published: (2018-12-01)

The pharmacogenomics of pain management: prospects for personalized medicine
by: Ting S, et al.
Published: (2016-02-01)

Comparison of CYP2C9, CYP2C19, CYP2D6, ABCB1, and SLCO1B1 gene-polymorphism frequency in Russian and Nanai populations
by: Sychev DA, et al.
Published: (2017-03-01)

Clinical Implications of Combinatorial Pharmacogenomic Tests Based on Cytochrome P450 Variant Selection
by: Michael Sayer, et al.
Published: (2021-09-01)

The concept of gene is in crisis. Does it affect pharmacogenetics and pharmacogenomics?
by: Miriam Falkenberg, et al.
Published: (2006-09-01)

Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example
by: Kisor DF, et al.
Published: (2021-05-01)

Pharmacogenomics of neuropathic pain
by: Vandana Sharma
Published: (2017-01-01)

Multi-Ethnic Analysis of Cardiac Pharmacogenetic Markers of Cytochrome P450 and Membrane Transporters Genes in the Russian Population
by: K. B. Mirzaev, et al.
Published: (2019-07-01)

Drug Use in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines from CPIC or DPWG for CYP2D6 and CYP2C19 Drug–Gene Pairs: Perspectives for Introducing PGx Test to Polypharmacy Patients
by: Niels Westergaard, et al.
Published: (2020-01-01)

Association of polymorphism of CYP2D6 and CYP2C9 genes encoding P-450 proteins of cytochrome with arterial hypertension
by: Saratsev A.V., et al.
Published: (2012-12-01)

Pharmacogenomics in Oncology Care
by: Kelly K Filipski, et al.
Published: (2014-04-01)

Web Resources for Pharmacogenomics
by: Guoqing Zhang, et al.
Published: (2015-02-01)

Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry
by: Joseph P. Jarvis, et al.
Published: (2019-06-01)

“Late” Withdrawal Syndrome after Carbamazepine In Utero Exposure in a CYP2C9 Slow Metabolizer Newborn
by: Caroline F. Samer, et al.
Published: (2017-04-01)

Estimation of CYP3A4*1B single nucleotide polymorphism in patients with recurrent Major Depressive Disorder
by: Rafał Świechowski, et al.
Published: (2019-06-01)

Update on the pharmacogenomics of pain management
by: Kaye AD, et al.
Published: (2019-07-01)

Pharmacogenetics of Cytochrome P450 2B6 (CYP2B6): Advances on Polymorphisms, Mechanisms, and Clinical Relevance
by: Ulrich M Zanger, et al.
Published: (2013-03-01)

Effect of the CYP3A5, CYP3A4, CYP3A7, ABCB1, POR and NR1I2 genes in the pharmacokinetics of tacrolimus in a pediatric cohort with stable serum concentrations after renal transplantation: study protocol.
by: Irene Dapia, et al.
Published: (2017-01-01)

Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the Chilean population: comparison with Caucasian and Asian populations
by: Angela Margarita Roco, et al.
Published: (2012-11-01)

Clinical Application and Evaluation of Pharmacogenomics in Tumor Chemotherapy
by: Jifeng Feng
Published: (2014-03-01)

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial
by: Nicholas L. Syn, et al.
Published: (2018-07-01)

Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact
by: Claudia Maria Hattinger, et al.
Published: (2020-06-01)

Pharmacogenomics: introduction and use in clinical practice
by: Saunders Hollie, et al.
Published: (2020-06-01)

Genetic variations in the drug metabolizing enzyme, CYP2E1, among various ethnic populations of Pakistan
by: Sagheer Ahmed, et al.
Published: (2020-08-01)

Pharmacokinetics of diclofenac in healthy controls with wild-type phenotype for CYP2C9 shows metabolism variability
by: M. Martín-De Saro, et al.
Published: (2017-04-01)

Curriculum in Pharmacogenetics and Pharmacogenomics in the Colleges and Schools of Pharmacy in the United States
by: Adams, Laura, et al.
Published: (2009)

Pharmacogenomics in the newborn
by: Mirta Corsello, et al.
Published: (2013-08-01)

Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
by: Kristi Krebs, et al.
Published: (2019-08-01)

Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection
by: Alfredo B. Cuéllar-Barboza, et al.
Published: (2020-07-01)

A Survey of Pharmacogenomics Testing Among Physicians, Pharmacists, and Researchers From China
by: Chengxian Guo, et al.
Published: (2021-07-01)

The Impact of CYP3A5 Genotype on the Interaction Between Tacrolimus and Intravenous Nicardipine in Kidney Transplant Recipients
by: Hooper, David K.
Published: (2010)

A Web-Based Pharmacogenomics Search Tool for Precision Medicine in Perioperative Care
by: Sara Zarei, et al.
Published: (2020-07-01)

A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents
by: Thomas Dodsworth, et al.
Published: (2018-07-01)